ACTA2 and idiopathic pulmonary fibrosis: MMT was supported in vivo in the idiopathic pulmonary fibrosis (IPF) patients via single-cell RNA sequencing (scRNA seq) where approximately 50% of ACTA2+ cells also exhibited positivity for the macrophage marker CD68 suggesting presence MMT in vivo49.